Session Details
[27-64-pm1]Drug design, Medicinal Chemistry, Others
Fri. Mar 27, 2026 1:10 PM - 3:10 PM JST
Fri. Mar 27, 2026 4:10 AM - 6:10 AM UTC
Fri. Mar 27, 2026 4:10 AM - 6:10 AM UTC
Room 64 (Collaboration Commons, RINPUKAN [1F]) (2)
Discusser: Yohei Saito, Fumika Karaki
[27-64-pm1-10]Investigation of Separation Conditions of GLP-1 Receptor Agonist Semaglutide Using AI Algorithms and Prep Purification
○Yusuke Masuda1, Tomoko Kuriki1, Ryo Kubota1 (1. Shimadzu Corporation)
[27-64-pm1-11]Confirmation of Molecular Weight and Amino Acid Sequence of Synthetic Peptides using MALDI-TOF MS
○Kumiko Yamaguchi1, Tomoko Kuriki1, Takashi Nishikaze1, Ryo Yamaguchi1 (1. Shimadzu Corporation SCOE)
[27-64-pm1-12]Development of selective chaperone compounds for Gaucher disease based on C4-position derivatisation of pyrrolidine-type iminosugars
○Atsushi Kato1, Kosuke Yoshimura1, Suzuka Yamamoto1, Atsumi Taguchi1, Takuya Okada2, Naoki Toyooka2, Izumi Nakagome3, Nobutada Tanaka3 (1. Department of Hospital Pharmacy, University of Toyama, 2. Graduate School of Science and Engineering, University of Toyama, 3. School of Pharmaceutical Sciences, Kitasato University)
[27-64-pm1-13]Development of Acetyl-Glucose modified Panobinostat derivatives as radiosensitizer
○Momoka Ishi1, SAYA KOBAYASHI1, YUSEI SHINOHARA2, HISATSUGU YAMADA2, YOSHIHIRO UTO2 (1. Grad. Sch. of Adv. Sci. and Tech. Innov., Tokushima Univ., 2. Grad. Sch. Tech. Ind. Soc. Sci., Tokushima Univ.)
[27-64-pm1-14]AI-Driven Evolution of Structure-Activity Relationships for Drug Design
○CHING-HO CHI1, Keng-Chang Tsai 2, Hsin-Yi Hung1 (1. Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, 2. National Research Institute of Chinese Medicine, Ministry of Health and Welfare)
[27-64-pm1-15]The research of nucleic acid drugs against SARS-CoV-2
○Haruka Yamanaka1 (1. MP, Tokyo univ of Sci.)
[27-64-pm1-16]Development and evaluation of prodrug compounds triggered by lysine deacetylation
○Yuhei Ohta1, Shunya Shimokado2, Hirotaka Yamamoto2, Shoko Okazaki2, Keizo Takeshita2, Mitsuyasu Kawaguchi1, Hidehiko Nakagawa1 (1. Grad. Sch. Pharm. Sci., Nagoya City Univ., 2. Fac. Pharm. Sci., Sojo Univ.)
[27-64-pm1-17]Search for a potent inhibitor of melanogenesis from secondary metabolites of the soil fungus
○Tadahiro Etoh1, Haruna Mizusawa1, Kizashi Sudo1, Daiya Ichimaru1, Honoka Koike1, Masato Iwatsuki2,3, Yongpil Kim1 (1. Faculty of Pharmacy, Iryo sosei Univ. , 2. Graduate School of Infection Control Sciences, Kitasato Univ., 3. Ōmura Satoshi Memorial Institute, Kitasato Univ.)
[27-64-pm1-18]Exploration of Polyamine Derivatives with Selective Inhibitory Activity against SMOX
○Yuta Muraoka1, Takayama Jun1, Takeshi Uemura1, Takeshi Sakamoto1 (1. Fac. Pharm. Sci., Josai Univ)
[27-64-pm1-19]Development of therapeutic drugs for respiratory diseases utilizing the cellular defense mechanism of selective autophagy
○Satoshi Mizuta1, Tomoko Yamaguchi1, Iwanaga Naoki2, Matsumoto Gen3 (1. Grad. Sch. Biomed. Sci., Nagasaki Univ., 2. Nagasaki Univ. Hospital, 3. Osaka Metropolitan Univ.)
[27-64-pm1-20]Synthesis and Biological Evaluation of Analogues of Pine-Derived Compounds for Anti-Obesity Drug Development
○Yuka Matsunaga1, Aki Nakatsu1, Ayu Wakatsuki1, Kota Nomura1, Hiroki Yoshioka2,3, Tomohiro Yamaguchi2, Yutaka Aoyagi2 (1. Harima Chemicals, inc., 2. College of pharmacy, Kinjo Gakuin University, 3. Kitasato University School of Medicine)